MECOM and cancer: Given the complex biological nature of human cancer, genome-wide analyses, including epigenomics, genomics, proteomics and metabolomics studies, are warranted to further investigate and characterize key signaling pathways and networks and critical elements associated with leukemia containing the MECOM rearrangement.